The effects of chronic morphine on the generalization of buprenorphine stimulus control: An assessment of kappa antagonist activity

The effects of chronic morphine on the generalization of buprenorphine stimulus control: An... Rats trained to discriminate the mixed mu agonist/kappa antagonist buprenorphine from its vehicle generalize buprenorphine control to morphine. Buprenorphine, however, does not generalize to MR2266. The generalization to morphine suggests that buprenorphine's mu agonist properties mediated in part its discriminative control. The failure to generalize to MR2266, a compound reported to block kappa-mediated effects, however, suggests that its kappa antagonist activity was not involved in its discriminative effects. The ability of buprenorphine's mu (but not kappa) activity to establish stimulus control may be a function of the overshadowing of the kappa properties of buprenorphine by its concurrent mu activity. To test this possibility, in the present experiment rats were chronically exposed to morphine prior to buprenorphine discrimination training. This procedure has been reported to result in tolerance to buprenorphine's mu agonist effects and a more pronounced display of its kappa antagonist properties. The rats were then tested for the generalization of buprenorphine control to morphine, MR2266, and pentobarbital. As expected, buprenorphine failed to generalize to the nonopioid pentobarbital. Although subjects were tolerant to morphine (as evidenced by reductions in morphine-induced behavioral effects and a rightward shift in the doses of morphine substituting for buprenorphine), buprenorphine still failed to generalize to MR2266. The failure of buprenorphine to generalize to MR2266 under conditions that should have allowed for the development of stimulus control by buprenorphine's kappa antagonist activity was discussed in terms of the general inability of kappa antagonist activity to support discrimination learning. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmacology Biochemistry and Behavior Elsevier

The effects of chronic morphine on the generalization of buprenorphine stimulus control: An assessment of kappa antagonist activity

Loading next page...
 
/lp/elsevier/the-effects-of-chronic-morphine-on-the-generalization-of-buprenorphine-Fd0MBQUQSg
Publisher
Elsevier
Copyright
Copyright © 1995 Elsevier Ltd
ISSN
0091-3057
eISSN
1873-5177
DOI
10.1016/0091-3057(95)00180-5
Publisher site
See Article on Publisher Site

Abstract

Rats trained to discriminate the mixed mu agonist/kappa antagonist buprenorphine from its vehicle generalize buprenorphine control to morphine. Buprenorphine, however, does not generalize to MR2266. The generalization to morphine suggests that buprenorphine's mu agonist properties mediated in part its discriminative control. The failure to generalize to MR2266, a compound reported to block kappa-mediated effects, however, suggests that its kappa antagonist activity was not involved in its discriminative effects. The ability of buprenorphine's mu (but not kappa) activity to establish stimulus control may be a function of the overshadowing of the kappa properties of buprenorphine by its concurrent mu activity. To test this possibility, in the present experiment rats were chronically exposed to morphine prior to buprenorphine discrimination training. This procedure has been reported to result in tolerance to buprenorphine's mu agonist effects and a more pronounced display of its kappa antagonist properties. The rats were then tested for the generalization of buprenorphine control to morphine, MR2266, and pentobarbital. As expected, buprenorphine failed to generalize to the nonopioid pentobarbital. Although subjects were tolerant to morphine (as evidenced by reductions in morphine-induced behavioral effects and a rightward shift in the doses of morphine substituting for buprenorphine), buprenorphine still failed to generalize to MR2266. The failure of buprenorphine to generalize to MR2266 under conditions that should have allowed for the development of stimulus control by buprenorphine's kappa antagonist activity was discussed in terms of the general inability of kappa antagonist activity to support discrimination learning.

Journal

Pharmacology Biochemistry and BehaviorElsevier

Published: Dec 1, 1995

References

  • Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: Comparisons with opioid receptor agonists
    Ben-Sreti, M.M.; Sewell, R.D.E
  • Discriminative stimulus properties of naloxone
    Carter, R.B.; Leander, J.D.
  • Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
    Cowan, A.; Lewis, J.W.; MacFarlane, I.R.
  • In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions
    Dum, J.E.; Herz, A.
  • Animal models of drug withdrawal symptoms
    Emmett-Oglesby, M.M.; Mathis, D.A.; Moon, R.T.Y.; Lal, H.
  • Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys
    France, C.P.; Woods, J.H.
  • Opioid agonist and antagonist behavioural effects of buprenorphine
    Leander, J.D.
  • Discriminative response control by naloxone in morphine pretreated rats
    Miksic, A.; Sherman, G.; Lal, H.
  • Aversive property of opioid receptor blockade in drug-naive mice
    Mucha, R.F.; Walker, M.J.K.
  • Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure
    Negus, S.S.; Picker, M.J.; Dykstra, L.A.
  • Motivational effects of opioids
    Shippenberg, T.S.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off